Jieqing Jiao
YOU?
Author Swipe
View article: Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study
Tau accumulation in autosomal dominant Alzheimer’s disease: a longitudinal [18F]flortaucipir study Open
View article: NiftyPAD - Novel Python Package for Quantitative Analysis of Dynamic PET Data
NiftyPAD - Novel Python Package for Quantitative Analysis of Dynamic PET Data Open
View article: Comparison of static and dynamic analysis techniques for longitudinal analysis of amyloid PET
Comparison of static and dynamic analysis techniques for longitudinal analysis of amyloid PET Open
Background Amyloid PET is a robust biomarker of cortical β‐amyloid accumulation and a candidate endpoint for Alzheimer’s prevention trials. Quantification typically uses Standard Uptake Value Ratio (SUVR) measures acquired over 10‐20 minut…
View article: Longitudinal (<sup>18</sup>F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation
Longitudinal (<sup>18</sup>F)AV-1451 PET imaging in a patient with frontotemporal dementia due to a Q351R MAPT mutation Open
Mutations in the microtubule associated protein tau ( MAPT ) gene are a common cause of inherited frontotemporal dementia (FTD) and result in the deposition of pathological tau protein in the brain.1 Tau positron emission tomography (PET) …
View article: Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept
Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept Open
Pharmacokinetic modelling on dynamic positron emission tomography (PET) data is a quantitative technique. However, the long acquisition time is prohibitive for routine clinical use. Instead, the semi-quantitative standardised uptake value …
View article: Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept
Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept Open
Pharmacokinetic modelling on dynamic positron emission tomography (PET) data is a quantitative technique. However, the long acquisition time is prohibitive for routine clinical use. Instead, the semi-quantitative standardised uptake value …
View article: Fast PET reconstruction using Multi-scale Fully Convolutional Neural Networks
Fast PET reconstruction using Multi-scale Fully Convolutional Neural Networks Open
Reconstruction of PET images is an ill-posed inverse problem and often requires iterative algorithms to achieve good image quality for reliable clinical use in practice, at huge computational costs. In this paper, we consider the PET recon…
View article: Direct Parametric Reconstruction With Joint Motion Estimation/Correction for Dynamic Brain PET Data
Direct Parametric Reconstruction With Joint Motion Estimation/Correction for Dynamic Brain PET Data Open
Direct reconstruction of parametric images from raw photon counts has been shown to improve the quantitative analysis of dynamic positron emission tomography (PET) data. However it suffers from subject motion which is inevitable during the…
View article: ASL-incorporated Pharmacokinetic Modelling of PET Data With Reduced Acquisition Time: Application to Amyloid Imaging
ASL-incorporated Pharmacokinetic Modelling of PET Data With Reduced Acquisition Time: Application to Amyloid Imaging Open
Pharmacokinetic analysis of Positron Emission Tomography (PET) data typically requires at least one hour of image acquisition, which poses a great disadvantage in clinical practice. In this work, we propose a novel approach for pharmacokin…
View article: Impact of image-based motion correction on dopamine D3/D2 receptor occupancy—comparison of groupwise and frame-by-frame registration approaches
Impact of image-based motion correction on dopamine D3/D2 receptor occupancy—comparison of groupwise and frame-by-frame registration approaches Open